Concepedia

Effects of the vasopressin (V1B) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat

Y. Claustre, L. Rouquier, Christophe Desvignes, Maud Leonetti, J. Montégut, N. Aubin, Nathalie Allouard, I. Bougault, Florence Oury-Donat, R. Steinberg

Neuroscience · 2006 · 12 citations · 31 references

DOI

Concepts

References

31

The rat brain in stereotaxic coordinates

Miklós Palkovits · Neuropeptides · 1983 · 29K citations

, , +7

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 459 citations · Full text

, , +24

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Richard Alonso, Guy Griebel, G Pavone et al. · Molecular Psychiatry · 2003 · 309 citations

, , +15

Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

Liesbeth van Londen · Neuropsychopharmacology · 1997 · 302 citations · Full text

, , +10

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders

Guy Griebel, Jacques Simiand, R. Steinberg et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 235 citations